Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.05
-0.08
(-1.94%)
USD |
NASDAQ |
Oct 23, 16:00
4.04
-0.01
(-0.25%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings EPS Diluted (Quarterly) : -1.805 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.805 |
| March 31, 2026 | -1.228 |
| December 31, 2025 | -1.247 |
| September 30, 2025 | -1.897 |
| June 30, 2025 | -1.443 |
| March 31, 2025 | -1.391 |
| December 31, 2024 | -0.7825 |
| September 30, 2024 | -1.147 |
| June 30, 2024 | -0.9044 |
| March 31, 2024 | -0.8301 |
| December 31, 2023 | -1.813 |
| September 30, 2023 | -2.273 |
| June 30, 2023 | -2.053 |
| March 31, 2023 | -4.244 |
| December 31, 2022 | -2.608 |
| September 30, 2022 | -2.103 |
| June 30, 2022 | -3.173 |
| March 31, 2022 | -2.260 |
| December 31, 2021 | -2.458 |
| September 30, 2021 | -0.5214 |
| June 30, 2021 | -4.418 |
| March 31, 2021 | -4.142 |
| December 31, 2020 | -2.962 |
| September 30, 2020 | -12.79 |
| June 30, 2020 | -15.47 |
| Date | Value |
|---|---|
| March 31, 2020 | -12.84 |
| December 31, 2019 | -12.33 |
| September 30, 2019 | -9.646 |
| June 30, 2019 | 0.9426 |
| March 31, 2019 | -12.76 |
| December 31, 2018 | -9.070 |
| September 30, 2018 | -7.655 |
| June 30, 2018 | -6.335 |
| March 31, 2018 | -6.30 |
| December 31, 2017 | -6.00 |
| September 30, 2017 | -4.20 |
| June 30, 2017 | -4.50 |
| March 31, 2017 | -4.80 |
| December 31, 2016 | -5.083 |
| September 30, 2016 | -3.60 |
| June 30, 2016 | -3.30 |
| March 31, 2016 | -2.40 |
| December 31, 2015 | -1.993 |
| September 30, 2015 | -1.80 |
| June 30, 2015 | -3.00 |
| March 31, 2015 | -1.80 |
| December 31, 2014 | -1.458 |
| September 30, 2014 | -0.90 |
| June 30, 2014 | -0.60 |
| March 31, 2014 | -0.60 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.04M |
| Total Expenses (Quarterly) | 35.04M |
| Enterprise Value | -38.06M |
| Earnings Yield | -152.5% |
| Normalized Earnings Yield | -152.51 |